Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 Jan 1;34(1):60–65. doi: 10.1523/JNEUROSCI.3473-13.2014

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2014 the authors 0270-6474/14/340060-06$15.00/0

PMC Copyright notice

Figure 3. — KCC2 antagonist VU-0240551 (VU) prevents the effects of CGRP on IPSP amplitudes and reversal potentials. IPSP amplitude (y-axis) as a function of membrane potential (x-axis) in cells recorded in the absence (empty diamonds) versus the presence (filled diamonds) of the KCC2 antagonist VU-0240551 (40 μm). Top right inset, Amplitude of IPSPs before (empty bars) versus after CGRP (filled bars) in the absence (left) versus presence (right) of VU-0240551. Bottom left inset, GABA-A reversal potential before (empty bars) versus after CGRP (filled bars) in the absence (left) versus presence (right) of VU-0240551.